What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Study invalidates molecule that identified cells latently infected with HIV The main weapon of HIV, which at the moment makes it invincible, is its ability to hide within the body. This is what makes up the so-called viral reservoir, which is made up of viruses that are introduced into cells that remain dormant and that, due to their inactivity, cannot be detected or des News Study questions the concept that high fat meals induce satisfaction and digestive well-being A study led by Vall d'Hebron Barcelona Campus Hospital, in collaboration with El Celler de Can Roca, and published in the scientific journal Neurogastroenterology and Motility shows that the fat present in meals can be reduced without affecting gastronomic satisfaction. Not only that, th News Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company Vall d'Hebron Barcelona Hospital Campus and IQVIA, the largest Contract Research Organization (CRO) worldwide, have signed a preferential collaboration agreement (Prime Site Agreement), which commits both institutions to work together in conducting clinical trials in a News April, Fabry disease awareness month The Fabry International Network (FIN) association has established the month of April as the "month of Fabry" to raise awareness and educate about this disease, a rare, progressive and with multi-organ involvement pathology. News A new European project awarded to the CIBBIM-Nanomedicine of the VHIR converts the Vall d'Hebron Campus into the health institution with the most active research projects in Nanomedicine of Europe For the first time, the Vall d'Hebron Campus has a FET Innovation (Future and Emerging Technologies) project that has been awarded within the Horitzo 2020 program to the CIBBIM-Nanomedicine. Drug Delivery and Targeting research group. Addressing and Pharmacological Release that leads Dr. Simó Sch News Juvenile ALS is a very singular and rare type of Amyotrophic Lateral Sclerosis Vall d’Hebron has organized the third Commemorative World Wide Day for the Amyotrophic Lateral Sclerosis (ALS). ALS is a neurodegenerative disease that leads to paralysis by affecting the motor neurons, with no treatment to cure or stop its development. ALS Multidisciplinary Unit of Vall d’Hebron News Vall d’Hebron and Daniel Bravo Foundation open the new Cystic Fibrosis Unit, a European pioneer The Vall d’Hebron University Hospital has started running the new Cystic Fibrosis Unit, counting with a designed infrastructure that will improve the efficiency of the attention to the patient, and it is pioneer in Europe. This project is possible thanks to the donation of Daniel Bravo Andreu Pri News As of 2019, Vall d'Hebron will become the headquarters of ICORD, a worldwide reference organization in rare diseases From January 2019, Vall d'Hebron Barcelona Hospital Campus is taking over as the headquarters and coordinator of the International Conference on Rare Diseases and Orphan Drugs (ICORD). At the last meeting held in September in Stockholm, the members of the ICORD committee unanimously decided that News Vall d'Hebron performs the first pancreatic tail resection with the Da Vinci robot The Hepatobiliopancreatic Surgery Service of Vall d'Hebron Hospital has performed the first pancreatic resection of a pancreatic tail tumor using a first generation Da Vinci robot. News Genetic predisposition favors cannabis use in people with ADHD People with ADHD are almost eight times more likely to use cannabis throughout their lives. The study has described four shared genetic regions in both disorders. The prevalence rate of substance use disorder in adult ADHD is 45%. Pagination Previous page ‹‹ Page 45 Next page ››